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Abstract Lymph nodes (LNs) contain innate-like lymphocytes that survey the subcapsular sinus
(SCS) and associated macrophages for pathogen entry. The factors promoting this surveillance
behavior have not been defined. Here, we report that IL7RhiCcr6+ lymphocytes in mouse LNs
rapidly produce IL17 upon bacterial and fungal challenge. We show that these innate-like
lymphocytes are mostly LN resident. Ccr6 is required for their accumulation near the SCS and for
efficient IL17 induction. Migration into the SCS intrinsically requires S1pr1, whereas movement
from the sinus into the parenchyma involves the integrin LFA1 and its ligand ICAM1. CD169, a sialic
acid-binding lectin, helps retain the cells within the sinus, preventing their loss in lymph flow. These
findings establish a role for Ccr6 in augmenting innate-like lymphocyte responses to lymph-borne
pathogens, and they define requirements for cell movement between parenchyma and SCS in what
we speculate is a program of immune surveillance that helps achieve LN barrier immunity.
DOI: 10.7554/eLife.18156.001
Introduction
Our ability to mount adaptive immune responses against skin-invading pathogens depends on the
delivery of antigens to lymph nodes (LNs) for encounter by naive lymphocytes (Cyster, 2010;
Qi et al., 2014). However, activation, clonal expansion and effector lymphocyte differentiation takes
several days, whereas pathogens can undergo marked replication in a matter of hours. The skin con-
tains immune effector cells that help keep pathogen replication in check, in a process referred to as
‘barrier immunity’ (Belkaid and Segre, 2014). Despite this, in many cases, intact pathogens travel
within minutes via lymph fluid to draining LNs. Indeed some pathogens, such as Yersinia pestis,
appear to have evolved to undergo marked expansion only after arrival in the LN (St John et al.,
2014). Recently, there has been evidence indicating the existence of barrier immunity within LNs.
The first LN cells exposed to lymph-borne antigens include the CD169+ macrophages that extend
between the subcapsular sinus (SCS) or medullary sinuses and the underlying parenchyma
(Barral et al., 2010; Iannacone et al., 2010; Phan et al., 2009). Crosstalk between sinus-associated
macrophages and IFNg precommitted CD8 T cells and NK cells is important for mounting rapid Th1-
like and NK cell responses against acute infection by Pseudomonas aeroguinosa, Salmonella
Zhang et al. eLife 2016;5:e18156. DOI: 10.7554/eLife.18156 1 of 29
RESEARCH ARTICLE
typhimurium and Toxoplasma gondii (Coombes et al., 2012; Kastenmu¨ller et al., 2012). IL17 is a
cytokine with roles in anti-bacterial and anti-fungal defense that is made abundantly by effector T
cells at epithelial surfaces (Littman and Rudensky, 2010). Whether IL17 is produced rapidly during
responses to subcapsular sinus-invaders in LNs is unclear.
In recent work, our group and others identified populations of innate-like (pre-formed effector)
lymphocytes that are enriched near the SCS in peripheral LNs and are pre-committed to produce
IL17 (Do et al., 2010; Doisne et al., 2009; Gray et al., 2012; Roark et al., 2013). These cells
express high amounts of the chemokine receptors Ccr6 and Cxcr6 as well as the cytokine receptor
IL7R, and they include a majority of ab T cells but also considerable numbers of gd T cells as well as
non-T cells (Gray et al., 2012). Within the IL17-committed gd T cell population a major subset
expresses a Vg4-containing TCR (according to the nomenclature of [Heilig and Tonegawa, 1986]),
and undergoes expansion in response to challenge with imiquimod or complete Freund’s adjuvant
(Gray et al., 2013; Ramirez-Valle et al., 2015; Roark et al., 2013). In previous work, we found that
innate-like lymphocytes isolated from peripheral LNs were heavily coated with CD169+ macrophage-
derived membrane fragments (‘blebs’) (Gray et al., 2012). This observation suggested there may be
strong adhesive interactions between these cells and the CD169+ macrophages. CD169 is the found-
ing member of the Siglec family of sialic acid-binding lectins (Crocker et al., 2007; Macauley et al.,
2014). Although CD169 is a defining feature of LN SCS macrophages and targeting antigens to
CD169 can promote antibody responses (Macauley et al., 2014), the function of CD169 on these
cells is not fully understood.
Pre-enrichment of innate-like lymphocytes near LN sinuses is thought to be important for allowing
very rapid responses against lymph-borne invaders (Gray et al., 2012; Kastenmu¨ller et al., 2012).
Despite this, it is not known whether IL17-committed innate-like lymphocytes in LNs respond rapidly
upon pathogen challenge, and little is understood about how these cells localize to or move in the
subcapsular region. In this study, we found IL7RahiCcr6+ innate-like lymphocytes were mostly LN res-
ident and they produced IL17 within hours of bacterial or fungal challenge. Their proximity to the
SCS was mediated by Ccr6 and was important for the rapid induction of IL17 following bacterial
challenge. Real time intravital two photon microscopy and in vivo labeling procedures revealed that
innate-like lymphocytes exchanged between the LN parenchyma and the SCS. Movement into the
eLife digest The lymphatic system is a network of vessels and a vital part of our immune
system. Amongst other things, the lymphatic system carries microbes that have entered the body –
for example via to a cut or mosquito bite – to small, oval-shaped organs called lymph nodes. The
lymph nodes are packed with immune cells that can be activated to help fight off infections,
however certain microbes actually replicate inside the lymph nodes themselves.
Lymph nodes protect themselves from these infections by having some pre-armed immune cells
that are ready to respond rapidly as soon as an invading microbe is detected. These cells, referred
to as innate-like lymphocytes, position themselves at the exposed surfaces of the lymph node – the
locations where microbes are most likely to enter the organ. However, it was not known which cues
caused these immune cells to assemble and remain at these locations.
Zhang et al. now reveal that a signaling molecule called CCL20 attracts the innate-like
lymphocytes to the lymph node’s exposed surfaces, while a protein known as CD169 helps to
securely attach the innate-like lymphocytes in place. Further experiments then confirmed that
positioning the innate-like lymphocytes at this location made mice more able to fight off the
disease-causing bacterium Staphyloccus aureus.
Unexpectedly, Zhang et al. also found that innate-like lymphocytes can move from the surfaces of
lymph node through to the underlying tissue. This unusual migratory behavior might allow the
lymphocytes to search a larger area for the infectious microbes, though further studies are needed
to test this hypothesis. Future studies are also likely to focus on elucidating how the innate-like
lymphocytes recognize different types of invaders, and how their activity keeps the lymph nodes
healthy.
DOI: 10.7554/eLife.18156.002
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Figure 1. Rapid induction of IL17 expression by IL7RahiCcr6+ innate-like lymphocytes in a CD169+ macrophage-dependent manner following bacterial
and fungal challenge. (A) Representative FACS plot showing IL7RahiCcr6+ staining of peripheral LN cells from a Cxcr6GFP/+ mouse, and Cxcr6-GFP
intensity on the gated cells. (B) Representative FACS plots showing CD3e, TCRb and TCRgd staining of the IL7RahiCcr6+ population. Bar graph shows
summary frequency data (mean ± sd) for more than 10 mice. (C) Intracellular FACS showing IL17 production among LN cells after 3 hr in vitro
Figure 1 continued on next page
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SCS was S1pr1 dependent, whereas return to the parenchyma involved LFA1 and ICAM1. Within the
SCS, CD169-mediated adhesive interactions that helped retain the cells, presumably against the
shear stresses exerted by lymph flow. This requirement was most prominent for the Vg4+gd T cell
subset of innate-like lymphocytes. These observations provide a model for understanding the mech-
anism by which innate-like lymphocytes survey the pathogen-exposed surface of the LN to protect
the organ from infection.
Results
IL7RahiCcr6+ innate-like lymphocytes near the SCS respond rapidly to
pathogens
IL7RahiCcr6+ innate-like lymphocytes within peripheral LNs express high amounts of Cxcr6 and they
include ~70% ab T cells, ~20% gd T cells and 5–10% non-T cells (Figure 1A,B) (Gray et al., 2012).
Consistent with previous findings, the IL7RahiCcr6+gd T cell subset produced IL17 rapidly upon
treatment with phorbol 12-myristate 13-acetate (PMA) and ionomycin or with the cytokines IL1b and
IL23 (Figure 1C, lower graph) (Cai et al., 2014; Gray et al., 2012; Gray et al., 2011). These treat-
ments also triggered rapid IL17 production from the IL7RahiCcr6+ab T cells (Figure 1C). We there-
fore tested whether both the ab and gd subsets of IL7RahiCcr6+ T cells produce IL17 in skin draining
LNs following bacterial or fungal challenge. IL17 is known to play a role in host defense against cuta-
neous Candida albicans and Staphyloccus aureus infection (Cho et al., 2010; Conti and Gaffen,
2015) and to be induced in rats by Y. pestis (Comer et al., 2010). Three hours after heat-killed C.
albicans, S. aureus bioparticle, or attenuated Y. pestis footpad challenge, IL17 production in draining
popliteal LNs was observed (Figure 1D). IL7RahiCcr6+ lymphocytes were the dominant IL17 pro-
ducers at this early time point after challenge (Figure 1D). The induction of IL17 expression in
IL7RahiCcr6+ cells upon bacterial challenge was dependent on CD169+ SCS macrophages as the
response was greatly blunted in CD169-DTR mice (Miyake et al., 2007) pretreated with DT to
ablate these cells (Figure 1E). Since IL1b and IL23 induced IL17 production from IL7RahiCcr6+ T cells
in vitro, we looked for expression of these cytokines after S. aureus bioparticle challenge. Transcripts
for both Il1b and Il23a were upregulated (Figure 1F). Induction of IL17 following S. aureus biopar-
ticle challenge was compromised in mice lacking the ASC (Apoptosis-associated speck-like protein
containing a CARD) inflammasome subunit (Figure 1G), consistent with a role for IL1b in activating
IL7RahiCcr6+ cells during the response to these bacteria.
IL7RahiCcr6+ innate-like lymphocytes are mostly LN resident
IL7RahiCcr6+ lymphocytes make up ~0.5% of peripheral LN cells yet they represent only ~0.1% of
cells in blood (Figure 2A), suggesting that the cells are largely non-recirculatory under homeostatic
conditions. To test this more directly, we ‘time stamped’ cells in inguinal LNs of KikGR photoconver-
tible protein-expressing transgenic mice by brief violet light exposure (Gray et al., 2013). At 24 hr
after photoconversion almost three quarters of the IL7RahiCcr6+ cells and a similar fraction of the
Vg4+Ccr6+ cells remained resident in the LN, whereas more than 80% of the conventional ab T cells
and Ccr6– Vg4+ T cells had left the LN and been replaced by newly arriving cells. At 48 hr, the
innate-like lymphocyte pool showed little further exchange, whereas naive ab T cells were 90%
replaced (Figure 2B). In a further approach, we examined the amount of cell exchange that occurred
in parabiotic mice. Two weeks following surgery the naive ab T cell compartment and the Ccr6–
Figure 1 continued
stimulation with IL1b and IL23 or phorbol 12-myristate 13-acetate and ionomycin. Graph shows summary data from 3 experiments. (D) Representative
FACS plots showing IL17 production among popliteal LN cells 3 hr after footpad challenge with heat inactivated C. albicans, S. aureus coated
bioparticles, and attenuated Y. pestis. Summary graph shows% IL17+ cells among IL7RahiCcr6+ cells. (E) IL17 production by IL7RahiCcr6+ cells in control
and CD169-DTR macrophage ablated mice treated with S. aureus bioparticles as in D, Summary graph shows% IL17+ cells among IL7RahiCcr6+ cells. (F)
Il1b and Il23a mRNA level in popliteal LNs of S. aureus bioparticle challenged mice relative to controls, determined by qRT-PCR. (G) Summary graph to
show% IL17+ cells among IL7RahiCcr6+ cells between control and ASC-deficient mice after 3 hr S. aureus bioparticle challenge. ***p<0.001 by student’s
t test. Data are representative of at least two experiments for panels A–C. Data are representative of two or more experiments with at least two mice
per group for panels D–G. LN, Lymph node.
DOI: 10.7554/eLife.18156.003
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Figure 2. IL7RahiCcr6+ innate-like lymphocytes are mostly LN resident. (A) Representative FACS plots showing frequency of IL7RahiCcr6+ and
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Vg4+ T cells had achieved full chimerism, whereas the innate-like lymphocytes showed only limited
exchange between the paired mice (Figure 2C). Taken together, these findings indicate that most
IL7RahiCcr6+ cells are resident in the LN for multiple days and are not extensively recirculating under
homeostatic conditions.
Migration dynamics of innate-like lymphocytes at the SCS
Cxcr6-GFP is highly expressed by all IL7RahiCcr6+ cells (Figure 1A), and in previous work, we
observed that Cxcr6GFP/+ cells migrate extensively in outer and inter-follicular regions, often in close
association with CD169+ SCS macrophages (Gray et al., 2012). A closer examination of Cxcr6GFP/+
cell behavior in this region revealed that the cells frequently made contact with CD169+ macro-
phages, and occasionally, lymphocytes could be observed crossing the layer of macrophages to
reach the SCS (Figure 3A and Videos 1 and 2). Reciprocally, cells that were initially detected within
the SCS could be observed migrating across the thick CD169+ macrophage layer into the LN paren-
chyma (Figure 3A and Videos 1 and 2). To quantify the crossing events, cell tracks were generated
automatically (Figure 3—figure supplement 1) and tracks crossing the SCS floor were manually enu-
merated. Among all the tracks of Cxcr6GFP/+ cells within 50 mm of the capsule, ~25% were in the
SCS (Figure 3B). Cell tracking analysis showed that about 3% of the cells in the SCS region traveled
from the parenchyma into the sinus, and 3% of the cells traveled in the reverse direction, in the 30
min imaging periods (Figure 3C).
To quantitate the proportion of cells in the LN lymphatic sinuses at a given moment in time, we
optimized an in vivo procedure to label lymph-exposed cells based on the established method of
antibody pulse-labeling of blood-exposed cells (Cinamon et al., 2008). We targeted Thy1 since this
marker is expressed by all the IL7RahiCcr6+ cells while not being present on SCS macrophages (not
shown). PE-conjugated antibody was used as the large size of PE (250 kD) reduces the rate at which
the antibody accesses the lymphoid tissue parenchyma (Pereira et al., 2009). Thy1-PE antibody
(0.2 mg) was injected into the footpad, the draining popliteal LN was isolated 5 min later and the fre-
quency of labeled cells determined by flow cytometry. Approximately 10% of the total IL7RahiCcr6+
cells were brightly labeled with Thy1-PE antibody compared with about 0.3% of naive T cells
(Figure 3D). Among the innate-like lymphocytes, gd T cells (predominantly Vg4+Ccr6+ cells) were
preferentially labeled, with around 15–20% of these cells being antibody exposed. By immunofluo-
rescence microscopy, Thy1-PE-labeled CD3e+ cells were observed in the SCS and in nearby lym-
phatic sinuses, and few labeled cells were detected within the LN parenchyma, confirming that
footpad injection of PE-conjugated antibody led to preferential labeling of lymph-exposed LN cells
(Figure 3E). The broader labeling of the sinus by Thy-1 than by CD3 reflects the expression of Thy1
by lymphatic endothelial cells (Jurisic et al., 2010).
We also obtained information about lymphocyte-SCS macrophage proximity by following up on
our finding that isolated innate-like lymphocytes are heavily coated with CD169+ macrophage-
derived membrane fragments (‘blebs’) (Gray et al., 2012). This coating is thought to occur at the
time of LN cell dissociation, possibly because the SCS macrophages are tightly bound to the extra-
cellular matrix and become fragmented during mechanical preparation of the tissue. Importantly,
the blebs only become bound to cells that are associated with the macrophages at the time of isola-
tion since co-preparation of LN cells from congenically distinct animals did not lead to cross acquisi-
tion of macrophage-derived blebs by innate-like lymphocytes from the different LNs (Gray et al.,
2012). In accord with previous findings, 30–40% of the IL7RahiCcr6+ innate-like lymphocytes isolated
from control mice were CD169 macrophage-derived membrane bleb positive (Figure 3F). A higher
frequency (40–55%) of the Vg4+gd T cells were CD169 bleb positive, suggesting these cells may be
preferentially associated with SCS macrophages (Figure 3F). Combining this analysis with Thy1-PE
labeling showed that lymph-exposed innate-like lymphocytes, but not total ab T cells, were enriched
for CD169-bleb-positive cells (Figure 3G). The Thy1-PE+ CD169– cells amongst total ab T cells most
likely correspond to recirculating cells that are exiting the LN via cortical and medullary sinuses.
Ccr6 promotes innate-like lymphocyte positioning near the SCS
Given the high Ccr6 expression on the innate-like lymphocyte population, we asked whether this
CCL20 receptor had a role in guiding innate-like lymphocytes to the subcapsular region. Although
CCL20 is not abundantly expressed in LNs, it is expressed in LN lymphatic endothelial cells (LECs) at
Zhang et al. eLife 2016;5:e18156. DOI: 10.7554/eLife.18156 6 of 29
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Figure 3. Migration dynamics, sinus exposure and CD169+ macrophage interaction of LN innate-like lymphocytes. (A) Time series of Cxcr6GFP/+ cell
movement with respect to CD169+ SCS macrophages. Upper panels: white arrow indicates a Cxcr6GFP/+ lymphocyte in the LN parenchyma that crosses
into the SCS. 300 s time series was taken from a 46 mm z stack. Lower panel: white arrow indicates a Cxcr6GFP/+ lymphocyte that begins in the SCS and
crosses into the LN parenchyma. 360 s time series was taken from a 34 mm z stack. Green, Cxcr6-GFP+ lymphocytes; Red, CD169+ macrophages; Blue,
second harmonic. White dashed line indicates boundary between SCS and LN parenchyma. (B, C) Percent tracks in SCS compartment among the total
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levels more than 100-fold higher than other LN lymphoid stromal cells (Figure 4A). Immunofluores-
cence microscopy showed evidence of CCL20 protein in the subcapsular sinus region (overlying fol-
licular and interfollicular regions) but not in the medullary sinus region (Figure 4B, Figure 4—figure
supplement 1) consistent with findings in primate LNs (Choi et al., 2003; Pegu et al., 2007). Innate-
like lymphocytes were responsive to CCL20 by in vitro migration assays (Figure 4C). When CCL20
was injected subcutaneously into Cxcr6GFP/+ mice, IL7RahiCcr6+Cxcr6hi lymphocytes became clus-
tered near and within the SCS in the draining LNs (Figure 4D, Figure 4—figure supplement 2).
Cells from these LNs showed reduced surface Ccr6, and increased CD169 staining and Thy1 label-
ing, consistent with their having been exposed to increased amounts of CCL20 and localizing near
and within the SCS (Figure 4E).
We next examined the distribution of Ccr6-
deficient (KO) cells in Ccr6GFP/GFP mice and found
that the cells were reduced in density near the
SCS (Figure 4F, Figure 4—figure supplement 3)
despite being slightly increased in total frequency
in the LN (not shown). Instead, the cells were
often distributed along the B-T zone interface
(Figure 4F, Figure 4—figure supplement 3). In
Thy1-PE labeling experiments, Ccr6 KO mice
showed reduced frequencies of labeled cells, a
result that was most significant for the Vg4+ pop-
ulation (Figure 4G). Consistent with reduced
proximity to SCS macrophages, Ccr6-GFP+
IL7Rahi cells and the Vg4+ subset from Ccr6 KO
mice were associated with less CD169+ blebs
compared with Ccr6-sufficient controls
(Figure 4H). The CD169+ macrophage popula-
tion in LN sections was unaffected by Ccr6-defi-
ciency (not shown).
Given that the Vg4+Ccr6+ cell population was
most dependent on Ccr6 for Thy1 labeling and
macrophage bleb acquisition (Figure 4G,H), we
further studied the properties of these cells. Vg4+-
Ccr6+ T cells uniquely express the surface marker
Scart2 (Figure 4I) (Gray et al., 2013;
Kisielow et al., 2008). In a complementary
approach to Thy1 labeling, Scart2 antibody treat-
ment was found to label fewer Vg4+ cells in LNs
from Ccr6-deficient mice than from wild-type mice
(Figure 4I). By immunofluorescence microscopy,
Scart2+ gd T cells were underrepresented in the
SCS region in LN sections from Ccr6-deficient
Figure 3 continued
tracks enumerated (B) and frequency of tracks crossing from the parenchyma into the SCS or out of the SCS into the parenchyma (C) in Cxcr6GFP/+
control mice. Each point represents data from a single movie (two independent experiments). (D) In vivo 5 min Thy1-PE labeling of IL7RahiCcr6+ cells,
Vg4+Ccr6+ cells and ab T cells, analyzed by flow cytometry. Data are representative of at least 10 mice. (E) In vivo Thy1-PE labeling of cells analyzed in
tissue sections. Costaining was with CD3-A488 (green) and Lyve1-A647 (blue). White arrows point out Thy1 and CD3 costained cells. (F) Frequency of
IL7RahiCcr6+, Vg4+Ccr6+ and naive ab T cells positive for CD169. Data are representative of 10 mice. (G) In vivo Thy1-PE labeling and CD169 staining
on IL7RahiCcr6+, Vg4+Ccr6+ and naive ab T cells, analyzed by flow cytometry. Data are representative of at least two experiments in each panel.
DOI: 10.7554/eLife.18156.005
The following figure supplement is available for figure 3:
Figure supplement 1. Example of automatically generated tracks for Cxcr6-GFP+ cells in a Cxcr6GFP/+ mouse LN.
DOI: 10.7554/eLife.18156.006
Video 1. Cxcr6-GFP+ cell shuttling between
parenchyma and the SCS. Representative intravital
time-lapse imaging of the popliteal LNs from two
Cxcr6GFP/+ mice. Overhead 3D video exemplifies the
dynamic movement of Cxcr6-GFP+ cells (green) within
the LN. Two-dimensional video of a 20 mm maximal
intensity projection from an orthogonal plane
demonstrates the anatomy of the SCS region. An
afferent lymphatic vessel (rarely visualized) drains into
the SCS, bounded by the collagenous LN capsule
(blue, second harmonic signal) and CD11b+ SCS
macrophages (red). The second example further
reveals the motility of Cxcr6-GFP+ cells both within the
SCS and the LN parenchyma. Cxcr6-GFP+ cells are
observed to cross from within the LN parenchyma into
the SCS, as well as from within the SCS into the LN
parenchyma (examples highlighted by circles). LN,
Lymph node; SCS, Subcapsular sinus.
DOI: 10.7554/eLife.18156.007
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mice compared with those from control mice
(Figure 4J, Figure 4—figure supplement 4).
Together these data support the conclusion
that Ccr6 plays a role in guiding innate-like lym-
phocytes toward the SCS region. Importantly,
when Ccr6 KO mice were immunized with S.
aureus bioparticles, the IL7RahiCcr6+ cells
mounted a diminished IL17 response (Figure 4K),
whereas they responded normally to activation
stimuli in vitro (not shown). These data provide
further evidence that proximity to SCS macro-
phages is important for innate-like lymphocytes
to mount rapid IL17 responses following patho-
gen exposure.
S1pr1 is required for innate-like
lymphocyte movement into the
SCS
S1pr1 is needed in naive lymphocyte for access
to cortical and medullary lymphatic sinuses dur-
ing LN egress (Cyster and Schwab, 2012). S1pr1
is also required for marginal zone (MZ) B cell
shuttling between the S1P high MZ and the S1P
low lymphoid follicle (Arnon et al., 2013). We
therefore tested whether S1pr1 played a role in
guiding innate-like lymphocytes into the SCS.
The innate-like lymphocytes had detectable surface S1pr1 (Figure 5A) and they responded to S1P
by in vitro migration in a Transwell assay (Figure 5B). Pretreatment of mice for 6 hr with FTY720, a
functional antagonist of S1pr1, greatly diminished in vivo Thy1-PE labeling on IL7RahiCcr6+ lympho-
cytes (Figure 5C). Similarly, in vivo Scart2 antibody labeling of Vg4+gd T cells was decreased after
FTY720 treatment (Figure 5D). FTY720 also decreased the CD169 membrane bleb positive fraction
to 20–25% in both the total IL7RahiCcr6+ population and the gd T cell subpopulation (Figure 5C).
The reductions in Thy1-PE-labeled cells (from ~10 to ~1%) and in CD169-bleb+ cells (from ~35
to~25%) were similar, representing ~10% of the total IL7RahiCcr6+ population in both cases
(Figure 5C), suggesting that the reduced frequency of CD169-bleb+ cells was due to the loss of cells
accessing the sinus. Comparable findings were made after treatment with the more selective S1pr1
functional antagonist, AUY954 (Figure 5E). These data provided evidence that S1pr1 was required
for the cells to have normal access to the SCS. Examination of tissue sections by immunofluores-
cence microscopy showed a loss of Cxcr6GFP/+ cells from the SCS following FTY720 treatment
(Figure 5F). FTY720 treatment also caused a depletion of Scart2+ cells from the SCS (Figure 5G,
Figure 5—figure supplement 1). When FTY720-treated mice were challenged with S. aureus biopar-
ticles, the IL7RahiCcr6+ population mounted an IL17 response of normal magnitude (not shown). We
speculate that SCS access is needed for other types of responses.
In mice unable to produce lymphatic S1P due to generalized Sphk2 deficiency and ablation of
Sphk1 in lymphatic endothelium, innate-like lymphocytes had less CD169+ macrophage-derived
membrane blebs and less in vivo Thy1-PE antibody labeling compared with control mice
(Figure 5H). These observations are consistent with the conclusion that the S1P-S1pr1 axis plays a
role in guiding innate-like lymphocytes into the SCS.
In accord with S1pr1 having an intrinsic role in promoting SCS access of IL7RahiCcr6+ cells, stain-
ing for S1pr1 and CD169 showed the macrophage-derived bleb coating was restricted to the
S1pr1+ cells (Figure 5I). This analysis required use of an unconjugated rat antibody to detect S1pr1.
Since the Thy1-PE is a rat antibody, it was not possible to combine the S1pr1 stain with the in vivo
Thy1-PE labeling procedure. To further test whether S1pr1 in innate-like lymphocytes was required
for SCS access, S1pr1f/f CreERt2+ mice were bred. Tamoxifen treatment of adult mice for 5 days
caused a loss of S1pr1 in innate-like lymphocytes (Figure 5J). Analysis in separate mice showed that
the loss of S1pr1 was associated with reduced in vivo Thy1-PE labeling and reduced CD169 on
Video 2. Representative examples of individual Cxcr6-
GFP+ cells crossing into and out of SCS. Intravital time-
lapse imaging of the popliteal LN from a Cxcr6GFP/+
control mouse, highlighting one cell crossing from the
parenchyma into the SCS, and one crossing from the
SCS into the parenchyma. Cells such as these that
clearly crossed from one region were manually
identified from automated tracking of all Cxcr6-GFP+
cells in an experiment. SCS, Subcapsular sinus.
DOI: 10.7554/eLife.18156.008
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Figure 4. Ccr6 promotes innate-like lymphocyte positioning near the SCS. (A) Ccl20 mRNA abundance in sorted LN lymphatic endothelial cells (LEC),
blood endothelial cells (BEC), fibroblastic reticular cells (FRC) and double negative stromal cells (DN) determined by qRT-PCR, shown relative to Hprt.
(B) CCL20 staining of LN section (red). The control (no primary) section was stained with the secondary anti-goat-Cy3 antibody alone. B cells were
detected in blue (B220). (C) Transwell migration of IL7RahiCcr6+ cells to CCL20. (D) Distribution of Cxcr6GFP/+ cells in LNs 3 hr after saline or CCL20 s.c.
Figure 4 continued on next page
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IL7RahiCcr6+ cells (Figure 5J). However, this approach could not exclude a role for S1pr1 in other
cell types. Attempts to test the intrinsic role of S1pr1 using BM chimeras were unsuccessful due to
difficulties in achieving efficient reconstitution of IL7RahiCcr6+ cells and our finding that many of the
cells developing in the chimeric mice appeared activated based on CD69 expression (not shown). In
another approach, mice were treated with tamoxifen for a short time to cause a ~50% reduction in
the fraction of cells that were S1pr1+ (Figure 5K). We reasoned that if S1pr1 were acting cell intrinsi-
cally in IL7RahiCcr6+ cells then under conditions of partial ablation the S1pr1-deleted cells should
lose their CD169 association whereas this would not occur if the receptor were acting in another cell
type. Consistent with an intrinsic role, there was little CD169 staining of S1pr1-negative cells in the
tamoxifen-treated mice (Figure 5K). These data support the conclusion that S1pr1 acts intrinsically
in innate-like lymphocytes to promote close associations with SCS macrophages.
We also examined the effect of S1pr1 antagonism on innate-like lymphocyte migration dynamics
using intravital two photon microscopy. Visual inspection of the imaging data for FTY720-treated ver-
sus control LNs suggested that there were fewer Cxcr6GFP/+ innate-like lymphocytes in the SCS after
FTY720 treatment and less examples of cells migrating into the sinus (Video 3). Quantification of the
number of tracks present in the SCS and the parenchyma in four imaging experiments confirmed that
there were fewer cells in the sinus (Figure 5L), and there was a significant reduction in the number of
tracks that crossed from the parenchyma into the sinus (Figure 5M). We also plotted the frequency of
cells versus distance from the LN capsule for multiple experiments determined using a computational
approach (see Materials and methods) and this confirmed that FTY720 caused a depletion of
Cxcr6GFP/+ cells from the sinus region (Figure 5—figure supplement 2). These data are consistent
with the conclusion that S1pr1 antagonism prevents innate-like lymphocyte access to the sinus.
Involvement of LFA1 and ICAM1 in innate-like lymphocyte access to the
LN parenchyma from the SCS
Cell movement from vascular locations into the tissue parenchyma often involves integrin-mediated
adhesion. Innate-like lymphocytes express high levels of LFA1 (aLb2) integrin (Figure 6A) and
ICAM1 is highly expressed by LECs lining the SCS (Cohen et al., 2014) (Figure 6B). ICAM1 is also
expressed by CD169+ SCS macrophages (not shown). In adhesion assays, IL7RahiCcr6+ cells bound
avidly to ICAM1 (Figure 6C). The Vg4+ subset had slightly lower LFA1 than the total IL7RahiCcr6+
population and adhered less strongly to ICAM1 (Figure 6A,C). Given these findings, we
Figure 4 continued
injection. Sections were stained to detect Cxcr6-GFP (green) and Lyve1 (blue). (E) Representative FACS plots show Ccr6 surface level, in vivo Thy1-PE
labeling and CD169 macrophage bleb level on IL7RahiCcr6+ cells from control (con) or CCL20 injected mice. Summary graph shows comparison of
Thy1-PE labeling and CD169+ staining frequency of IL7RahiCcr6+ and Vg4+Ccr6+ cells from control or CCL20 injected mice. (F) LN sections from
Ccr6GFP/+ or Ccr6GFP/GFP mice stained for EGFP (green) and B220 (blue). White arrow indicates subcapsular sinus area; FO: B cell follicle; T: T zone. (G)
Comparison of Thy1-PE labeling on IL7RahiCcr6+ cells from WT and Ccr6GFP/+ or Ccr6GFP/GFP mice. Ccr6 in Het and KO mice was detected based on
GFP reporter expression. (H) Comparison of CD169 staining on IL7RahiCcr6+ cells from WT, Ccr6GFP/+ or Ccr6GFP/GFP mice. (I) Representative FACS
plots showing Vg4+Scart2+ cells amongst gdT cells and the fraction that are Ccr6+ (upper), and in vivo Scart2-BV605 labeling and CD169 staining
(lower). Graph shows summary data. (J) LN sections from Ccr6 Het or KO mice stained for Scart2+ (green) and B220 (blue). White arrow indicates
subcapsular sinus area; FO: B cell follicle; T: T zone. (K) Representative histogram plot and summary mean fluorescence intensity (MFI) data of IL17
intracellular staining in IL7RahiCcr6+ LN cells from Ccr6 Het or KO mice 3 hr after S. aureus bioparticle challenge. *p<0.05, **p<0.01, ***p<0.001, by
student’s t test. Data are representative of at least two experiments for panel A–D, F, J. Data are representative of two or more experiments with at
least two mice per group for panels E, G–I, K. LN, Lymph node; SCS, Subcapsular sinus.
DOI: 10.7554/eLife.18156.009
The following figure supplements are available for figure 4:
Figure supplement 1. CCL20 distribution in inguinal LN.
DOI: 10.7554/eLife.18156.010
Figure supplement 2. Movement of Cxcr6-GFP+ cells to SCS location following CCL20 injection.
DOI: 10.7554/eLife.18156.011
Figure supplement 3. Ccr6 is required for positioning of Ccr6+ cells at the SCS.
DOI: 10.7554/eLife.18156.012
Figure supplement 4. Ccr6 is required for positioning of Scart2+gdT cells at the SCS.
DOI: 10.7554/eLife.18156.013
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Figure 5. S1pr1 is required for innate-like lymphocyte movement into the SCS. (A) S1pr1 surface expression on IL7RahiCcr6+ and Vg4+Ccr6+ cells from
control or FTY720 treated mice. Negative indicates samples stained with no primary antibody. (B) Transwell migration assay showing % of input cells
that migrated to the indicated amounts of S1P or SDF. (C) Representative FACS plots and summary data of in vivo Thy1-PE labeling and CD169
staining on IL7RahiCcr6+ and Vg4+Ccr6+ LN cells from control or FTY720 treated mice. (D) Summary graph showing in vivo Scart2 labeling on
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Zhang et al. eLife 2016;5:e18156. DOI: 10.7554/eLife.18156 12 of 29
Research article Immunology
hypothesized that LFA1-ICAM1 interaction may have a role in innate-like lymphocyte movement
from the SCS into the LN parenchyma. Consistent with this model, 6-hr aL blocking antibody treat-
ment caused increased Thy1-PE labeling on total IL7RahiCcr6+ lymphocytes and on the Vg4+gd T cell
subset, without influencing their total number in the LN (Figure 6D, Figure 6—figure supplement
1A). A similar increase in the frequency of Thy1-PE labeled innate-like lymphocytes was observed in
Icam1-/- mice compared to littermate controls (Figure 6E). However, Icam1-/- mice had less
IL7RahiCcr6+ and Vg4+Ccr6+ cells compared with ICAM1 sufficient control mice, whereas the cells
were present at an increased frequency in blood (Figure 6F,G). When mice were treated with aL
blocking antibody for 3 days, there was a similar
reduction in IL7RahiCcr6+ cell number in LNs and
a marked increase in their numbers in blood (Fig-
ure 6—figure supplement 1B). These data indi-
cate that, unlike short-term integrin blockade,
long-term deficiency of ICAM1 or sustained
blockade of LFA1 causes a loss of innate-like lym-
phocytes from the LN.
By immunofluorescence microscopy, IL7Rahi
cells were found enriched in the SCS in aL
blocked mice (Figure 6H). These data suggested
that innate-like lymphocytes were trapped in the
SCS following aL blockade, leading to their
increased exposure to the lymph-borne Thy1-PE
antibody. To further examine this possibility,
intravital two photon microscopy was performed,
comparing control and 6 hr aL blocked
Cxcr6GFP/+ mice. Visual inspection of the movies
revealed many Cxcr6GFP/+ cells that appeared to
be ‘stuck’ to the SCS floor with their cell bodies
‘fluttering’ in the sinus, possibly being moved by
passing lymph (Figure 6I and Video 4). These
cells had an elongated morphology compared to
the rounded shape of cells in the SCS of control
Figure 5 continued
IL7RahiCcr6+ Vg4+ cells from control or FTY720-treated mice. (E) Representative histogram plot and summary data of CD169 staining on IL7RahiCcr6+
and Vg4+Ccr6+ LN cells from AUY954-treated mice. (F) GFP, Lyve1 and TCRgd staining of LN sections from control and FTY720-treated Cxcr6-GFP+
mice. White, SCS: white arrow indicates subcapsular sinus area; FO: B cell follicle; T: T zone. (G) Scart2 and Lyve1 staining of LN sections from FTY720
treated and control mice. White arrow indicates subcapsular sinus area; FO: B cell follicle; T: T zone. (H) Summary data of in vivo Thy1-PE labeling and
CD169 staining of the indicated cells in Lyve1-Cre Sphk1fl/-Sphk2-/- (Sphk DKO) and control mice. (I) Representative FACS plot showing S1pr1 staining
on IL7RahiCcr6+ cells from a control mouse and histogram plots of CD169 staining on the indicated cells. (J) Representative FACS plot showing S1pr1
staining on IL7RahiCcr6+ cells from a control and 5-day tamoxifen-treated S1pr1f/f CreERt2 mouse, Graphs show summary data for frequency of Thy1-PE
labeled and CD169+ IL7RahiCcr6+ and Vg4+Ccr6+ cells in control (con) or tamoxifen (tam) treated mice. (K) Representative FACS plots of the type in I
for cells from a 2-day tamoxifen-treated S1pr1f/f CreERt2 mouse. Graph shows CD169+ cell frequency amongst S1pr1-negative IL7RahiCcr6+ cells.
*p<0.05, **p<0.01, ***p<0.001, by student’s t test. Data are representative of at least two experiments for panels A–B, E–G, I and two or more
experiments with at least two mice per group for panels C–D, H. Data are representative of at least three experiments with at least one control and one
S1pr1f/f CreERt2 mouse for panels J and K. (L) Percent tracks in SCS compartment among the total tracks enumerated in FTY720 treated mice. Each
point represents data from a single movie (three independent experiments). Dashed line is the mean for control mice (data shown in Figure 3B). The
frequency of cells in the SCS differed significantly from the control (p<0.05 by students t test). (M) Frequency of tracks crossing into and out of the SCS
of FTY720-treated mice, enumerated as in L. Dashed lines are the means for control mice (data shown in Figure 3C). Frequency of tracks crossing into
the SCS differed significantly from the control (p<0.05 by students t test). SCS, Subcapsular sinus.
DOI: 10.7554/eLife.18156.014
The following figure supplements are available for figure 5:
Figure supplement 1. FTY720 treatment depletes SCART2+gdT cells from the SCS.
DOI: 10.7554/eLife.18156.015
Figure supplement 2. Frequency of Cxcr6GFP/+ cells plotted against their depth from the surface of the LN capsule.
DOI: 10.7554/eLife.18156.016
Video 3. Cxcr6-GFP+ cellular dynamics following
FTY720 treatment. One hour time-lapse imaging of a
popliteal LN in a Cxcr6GFP/+ mouse 16 hr after
treatment with FTY720. Cxcr6-GFP+ cells (green) can be
seen accumulated on the parenchymal side of the SCS
macrophages (red, CD11b+), and depleted from the
SCS. LN capsule appears blue (second harmonic
signal).
DOI: 10.7554/eLife.18156.017
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Figure 6. LFA1 and ICAM1 control innate-like lymphocyte access to the LN parenchyma from the SCS. (A) Representative FACS histogram showing
LFA1 staining of IL7RahiCcr6+, Vg4+Ccr6+ and naı¨ve ab T cells. (B) ICAM1 staining of WT and ICAM1 KO LN sections. (C) Adhesion of IL7RahiCcr6+,
Vg4+Ccr6+ cells and naı¨ve ab T cells to ICAM1 or BSA. (D) Representative FACS plots and summary graph showing in vivo Thy1-PE labeling of
IL7RahiCcr6+ cells in 6 hr control or aL blocking antibody treated mice. (E) Summary graph showing in vivo Thy1-PE labeling of IL7RahiCcr6+ cells in
ICAM1 Het and KO mice. (F, G) IL7RahiCcr6+ and Vg4+Ccr6+ cell frequencies in LNs (F) and blood (G) from ICAM1 Het and KO mice. (H) Distribution of
IL7Rhi cells in LN sections from control and aL-antibody-treated mice. White, SCS: white arrow indicates subcapsular sinus area; FO: B cell follicle; T: T
zone. (I) Left panels: Time series of Cxcr6GFP/+ cells in LN of control or anti-aL treated mice. Mice were treated with CD11b-PE to label macrophages.
Right panel: Axis ratio of Cxcr6GFP/+ cells in control and anti-aL treated mice. Cxcr6GFP/+ cells in SCS contacting CD11b+ macrophages were measured.
Data are pooled from two independent experiments. *p<0.05, **p<0.01, ***p<0.001, by student’s t test. Data are representative of at least two
experiments for panels A–C, H–I and two or more experiments with at least two mice per group for panels D–G. (J) Percent of tracks in the SCS
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mice (Figure 6I and Video 4). Consistent with the in vivo Thy1-PE labeling and IF microscopy, quan-
titative analysis of the imaging experiments by enumerating cell tracks and by a computational
approach revealed that aL treatment caused an increase of cells in the sinus in association with the
macrophage layer (Figure 6J, Figure 6—figure supplement 1C). Moreover, the cell tracking analy-
sis showed that while there was not a significant change in the frequency of tracks crossing from the
parenchyma into the SCS, there was a significant reduction in cells traveling from the SCS into the
parenchyma (Figure 6K). These data support the conclusion that LFA1-ICAM1-mediated adhesion is
required for innate-like lymphocytes to migrate from the SCS into the LN parenchyma.
CD169 mediates SCS retention of innate-like lymphocytes
Our finding that innate-like lymphocytes are coated with CD169+ macrophage-derived membrane
blebs (Gray et al., 2012) together with in vitro evidence that CD169 can support adhesion of certain
cell types (Crocker et al., 1995; Crocker and Gordon, 1989; van den Berg et al., 2001) led us to
test whether CD169 contributed to innate-like lymphocyte migration or adhesion in the SCS. CD169
binds a2–3 linked sialic acid on surface glycoproteins (Macauley et al., 2014). By CD169-Fc staining,
we found IL7RahiCcr6+ lymphocytes had a high amount of CD169 ligand on their surface, and neur-
aminidase treatment of the cells abolished their ability to bind CD169 (Figure 7A). The acquisition
of abundant macrophage membrane fragments by innate-like lymphocytes was dependent on
CD169, since in mice in which CD169 was
blocked with a neutralizing antibody
(Crocker and Gordon, 1989) or in mice deficient
in CD169, there were no CD11b+ macrophage
membrane fragments on innate-like lymphocytes
(Figure 7B and Figure 7—figure supplement
1A).
By real-time two photon microscopy, CD169
blockade in Cxcr6GFP/+ mice appeared to
increase the amount of innate-like lymphocyte
migration within the SCS and between paren-
chyma and sinus (Video 5). Quantitation of the
cell tracks crossing between compartments con-
firmed that there was an increase in bidirectional
exchange (Figure 7C). We also examined Cxcr6-
GFP+ cells in CD169 KO mice and here too the
cells seemed to move extensively in the SCS
region (Video 5). These data are consistent with
the idea that CD169 blockade or deficiency dis-
rupts stable interactions between innate-like lym-
phocytes and SCS macrophages.
We therefore asked whether CD169 plays a
role in mediating lymphatic sinus retention of
innate-like lymphocytes. After 30 hr of treatment
with CD169-blocking antibody, there was no
change in total IL7RahiCcr6+ cell frequency, but
Figure 6 continued
compartment among the total tracks enumerated in anti-aL-treated mice. Each point represents data from a single movie (three independent
experiments). Dashed line is the mean for control mice (data shown in Figure 3B). The frequency of cells in the SCS differed significantly from the
control (p<0.05 by students t test). (K) Frequency of tracks crossing into and out of the SCS of anti-aL-treated mice, enumerated as in J. Dashed lines
are the means for control mice (data shown in Figure 3C). Frequency of tracks crossing out of the SCS differed significantly from the control (p<0.05 by
students t test). SCS, Subcapsular sinus.
DOI: 10.7554/eLife.18156.018
The following figure supplement is available for figure 6:
Figure supplement 1. Effects of aL blockade on innate-like lymphocyte distribution.
DOI: 10.7554/eLife.18156.019
Video 4. Cxcr6-GFP+ cell fluttering in the SCS
following aL blockade. In Cxcr6GFP/+ mice, four hours
after treatment with aL blocking antibody, Cxcr6-GFP+
cells (green) are observed to flutter at the floor of the
SCS. Cxcr6-GFP+ cells appear attached to CD11b+ SCS
macrophages (red) while being buffeted by bulk lymph
flow in the SCS, yielding a characteristic fluttering
dynamic (video inset and arrowheads). LN capsule
appears blue. LN, Lymph node; SCS, Subcapsular
sinus.
DOI: 10.7554/eLife.18156.020
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Figure 7. CD169 mediates SCS retention of innate-like lymphocytes. (A) CD169-Fc binding of innate-like lymphocytes. (B) Effect of CD169-deficiency or
blocking antibody treatment on macrophage bleb acquisition by IL7RahiCcr6+ cells. Cells were stained to detect the macrophage markers CD169 and
CD11b. (C) Frequency of tracks crossing into and out of the SCS of anti-CD169-treated mice. Each point represents data from a single movie (three
independent experiments). Frequency of tracks crossing into and out of the SCS differed significantly from the control (p<0.05 by students t test). (D)
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there was a two-fold loss of Vg4+Ccr6+ cells in the LN (Figure 7D). We speculated that if this loss
was occurring due to inhibited adherence of cells in the SCS then the lymph exposed cells might be
lost rapidly following CD169-blockade. Indeed, in 6-hr blockade experiments, there was a significant
reduction in the fraction of Vg4+Ccr6+ cells that were Thy1-PE labeled (Figure 7E). There was only a
slight reduction in the total numbers of Vg4+Ccr6+ cells after this short period (Figure 7—figure sup-
plement 1B) consistent with only a low fraction of the total population being in the sinus at a given
time. These observations suggest that CD169 blockade caused a loss of cells in lymphatic sinuses
and this in turn led to a loss of cells from the LN over time. A loss of Vg4+Ccr6+ cells was also
observed following CD169+ macrophage ablation using CD169-DTR mice (Figure 7F). In considering
explanations for why these effects were mostly selective to the Vg4+Ccr6+ subpopulation, we found
it notable that in ICAM1 adhesion assays, Vg4+Ccr6+ cells were less capable of binding ICAM1 com-
pared with other innate-like lymphocytes (Figure 6C). Taking this observation together with the find-
ing that a higher fraction of Vg4+Ccr6+ cells were lymph-exposed in the steady state (Figure 3D), we
speculated that the non-gdT innate-like lymphocytes – but not the Vg4+Ccr6+ cells – in the SCS were
able to travel back into the LN parenchyma even in the absence of CD169.
In an effort to reveal a role of CD169 in sinus
retention of the total innate-like lymphocyte pop-
ulation, we blocked aL prior to blocking CD169.
In the first 4 hr following aL treatment, we
observed a gradual increase in the fraction of
cells that were Thy1-PE+ (Figure 7G), consistent
with the accumulation of cells in the sinus (Fig-
ure 6). Within 2 hr of anti-CD169 treatment, this
enhanced Thy1 labeling was lost, indicating loss
of innate-like lymphocytes from the sinus, and
there was a reduction in IL7RahiCcr6+ cell fre-
quency (Figure 7G). IL7RahiCcr6+ cell frequency
declined further after 4 and 6 hr of double block-
ade (Figure 7G). When aL and CD169 were both
blocked continually for 6 hr, there was a 50% loss
of total innate-like lymphocytes in LNs, and this
was accompanied by an increase of the cells in
blood (Figure 7H). In CD169 Het and KO mice,
there were comparable starting frequencies of
IL7RahiCcr6+ cells (Figure 7—figure supplement
1C), but after aL blocking antibody treatment
there was a loss of Thy1-PE labeling and in total
IL7RahiCcr6+ cells in the CD169 KO mice com-
pared with the Het controls (Figure 7I).
The decrease in innate-like lymphocytes in LNs
6 hr after aL and CD169 double blockade was
also evident in intact LNs visualized by real-time
Figure 7 continued
Number of Vg4+Ccr6+ cells in LN after 30 hr of CD169 blockade. (E) In vivo Thy1-PE labeling on Vg4+Ccr6+ cells after 6 hr CD169 blockade. (F) Number
and in vivo Thy1-PE+-labeled Vg4+Ccr6+ cell frequency in LNs of control (con) or CD169-DTR+ mice after DT treatment. (G) Change in innate-like
lymphocyte frequency and Thy1-PE labeling over time after treating mice with aL and CD169 blocking antibodies. (H) Effect of 6 hr combined aL and
CD169 blockade on IL7RahiCcr6+ cell frequency in LN and blood, and fraction of LN cells that are in vivo Thy1-PE labeled. (I) Effect of aL blocking in
CD169 KO mice on IL7RahiCcr6+ cell number and in vivo Thy1-PE labeling. (J) IL7RahiCcr6+ cell adhesion to CD169-Fc and R97A-Fc-coated plates.
*p<0.05, **p<0.01, ***p<0.001, by student’s t test. Data are representative of at least two experiments for panels A–B, F, I. Data are representative of
two or more experiments with at least two mice per group for panels C–E, G–H. LN, Lymph node; SCS, Subcapsular sinus.
DOI: 10.7554/eLife.18156.021
The following figure supplement is available for figure 7:
Figure supplement 1. Effects of CD169 blockade on innate-like lymphocyte properties and distribution.
DOI: 10.7554/eLife.18156.022
Video 5. Increased movement of SCS Cxcr6-GFP+ cells
after CD169 blockade and in CD169–/– mice.
Representative time-lapse images of Cxcr6GFP/+ mice 4
hr after treatment with CD169 blocking antibody, as
well as Cxcr6GFP/+ CD169–/– mice. In both conditions,
there appeared to be an increased frequency of Cxcr6-
GFP+ cell (green) crossing events, both from the SCS
into the LN parenchyma and from the parenchyma into
the SCS. LN capsule appears blue and SCS
macrophages (CD11b) red. LN, Lymph node; SCS,
Subcapsular sinus.
DOI: 10.7554/eLife.18156.023
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two photon microscopy (Video 6). Importantly,
unlike aL blockade, which caused many innate-
like lymphocytes to become non-migratory and apparently stuck to the SCS floor (Video 4), applying
anti-CD169 in addition to anti-aL led to innate-like lymphocyte detachment from CD169+ macro-
phages and loss in the lymph flow (Video 7). In some regions, it was also possible to observe cells
moving from the parenchyma into the sinus, but then failing to attach and being carried away in the
lymph flow (Video 7). By quantitative analysis of three imaging experiments, CD169-blockade or
deficiency was found to have little effect on the density of Cxcr6GFP/+ cells in the SCS, but combined
aL and anti-CD169 treatment caused a decrease of cells from the sinus region (Figure 7—figure
supplement 1D,E). These data provide evidence that CD169 has a role in mediating lymphatic sinus
retention of most innate-like lymphocytes.
Finally, we examined the sufficiency of CD169 to support adhesive interactions of innate-like lym-
phocytes. In adhesion assays, IL7RahiCcr6+ lymphocytes showed binding to plates coated with
recombinant WT but not a binding site mutant of CD169 (Figure 7J). By contrast, naı¨ve ab T cells
showed minimal binding to CD169 (Figure 7J).
Discussion
The above findings show that the Ccr6-dependent positioning of IL7RahiCcr6+ innate-like lympho-
cytes near the LN SCS is important for their rapid cytokine production following bacterial or fungal
challenge. The data support a model (Figure 8) where lymphatic endothelial-derived CCL20 acts on
Ccr6 to attract the innate-like lymphocytes into proximity with SCS macrophages. This enhances
their exposure to macrophage-derived cytokines that promote IL17-production and likely other
effector functions of the lymphocytes
Our findings also reveal an unusual migratory behavior of innate-like lymphocytes in the SCS
region that involves exchange of cells between the parenchyma and SCS. Movement across the
CD169+ macrophage layer into the sinus is promoted by S1pr1 and lymphatic endothelial cell-
derived S1P. Within the sinus CD169 on macrophages binds to sialylated ligands on the innate-like
lymphocytes and helps prevent loss of the cells in lymph flow, with the Vg4+ subset of innate-like
lymphocytes being most dependent on this adhesive system. LFA1 binding to ICAM1 also
Video 6. Decreased Cxcr6-GFP+ cell frequency in SCS
following aL and CD169 double blockade. Decreased
numbers of Cxcr6-GFP+ cells (green) are observed in
the SCS and LN parenchyma following dual antibody
blockade of aL and CD169. Time-lapse imaging in a
Cxcr6GFP/+ mouse beginning 4 hr post treatment. LN
capsule appears blue and SCS macrophages (CD11b)
red. LN, Lymph node; SCS, Subcapsular sinus.
DOI: 10.7554/eLife.18156.024
Video 7. Addition of CD169 blockade causes release
of Cxcr6-GFP+ cells from floor of SCS when pre-treated
with aL blocking antibody. Representative time-lapse
imaging beginning 5 min after treatment with CD169
blocking antibody in Cxcr6GFP/+ mice pretreated 4 hr
before with aL blocking antibody. Upon addition of
CD169 blockade, Cxcr6-GFP+ cells (green) detached
from the floor of the SCS and entered the bulk lymph
flow, rapidly moving away from the field of view (inset
and arrowheads). LN capsule appears blue and SCS
macrophages (CD11b) red. LN, Lymph node; SCS,
Subcapsular sinus.
DOI: 10.7554/eLife.18156.025
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contributes to retaining innate-like lymphocytes in the sinus. Finally, return of cells to the paren-
chyma involves LFA1 and ICAM1, presumably to support transmigration across the lymphatic endo-
thelium. Although this local migratory behavior was not essential for mounting IL17 responses
against the pathogens tested in this study (data not shown), we propose that this surveillance pro-
gram allows innate like lymphocytes to interrogate the CD169+ macrophages and SCS for pathogen-
or commensal-derived molecules for which they have appropriate receptors.
The cues required for homeostatic positioning of cells in LN T zone and follicles have been well
studied, with CCL21/CCL19 and CXCL13 having dominant roles (Cyster, 2005). Our findings add
CCL20 as an additional homeostatic organizer, acting to recruit Ccr6+ IL17-committed cells to the
LN SCS region. As well as expression by innate-like lymphocytes, Ccr6 is abundant on Th17 cells
(Littman and Rudensky, 2010) and we speculate that Th17 effector cells that remain in the LN fol-
lowing immunization or infection may position in proximity with the SCS. Although Cxcr6 is also
abundantly expressed by innate-like lymphocytes, Cxcr6-deficiency did not appear to affect their dis-
tribution in the LN (unpubl. obs). The expression of CCL20 in a subcapsular region in primate LNs
(Choi et al., 2003; Pegu et al., 2007) makes it likely that our findings with Ccr6 in mice will extend
to humans. Ccr6 antagonism was suggested to reduce the egress of Ccr6+ effector CD4 T cells from
LNs in a mouse EAE model (Liston et al., 2009). CCL20 can be strongly induced in inflamed tissue
(Mabuchi et al., 2013), and we speculate that under the inflammatory condition associated with
EAE, CCL20 travels to LNs from the inflamed site and attracts Ccr6+ cells into the sinus lumen as we
observed following CCL20 injection. In the case of Ccr6+ CD4 effector T cells, this might then favor
their exit from the LN.
S1P and S1pr1 have a critical role in promoting egress of T and B cells from LNs, acting at the
step of transmigration into cortical and medullary sinuses (Grigorova et al., 2009; Sinha et al.,
2009). We describe here a further function for this ligand-receptor pair in promoting cell migration
into the SCS. As for movement into cortical and medullary sinuses, this response involves S1P pro-
duction by lymphatic endothelial cells. S1pr1 on naive lymphocytes is required during the egress
commitment step and did not appear to have a role in promoting chemotaxis to the sinus
(Grigorova et al., 2009). Consistent with those findings, we did not observe an obvious effect of
S1pr1 antagonism on innate-like lymphocyte density near the SCS, only a loss of cells from within
the sinus. We therefore favor the model that the cells approach the sinus-lining lymphatic endothelial
cells in a CCL20-dependent manner and S1pr1 commits some of the cells to cross the lymphatic
endothelium (and associated CD169+ macrophage layer) and enter the sinus. Within the sinus, we
anticipate that the cells are exposed to high amounts of S1P that cause rapid, GRK2-dependent
A B C
Figure 8. Model of requirements for innate-like lymphocyte surveillance of the LN SCS. (A) Diagram of skin draining LN. (B) Model showing effect of
Ccr6-deficiency on innate-like lymphocyte positioning and associated defect in ability to upregulate IL17 in response to IL1-family cytokines produced
by SCS macrophages in an ASC-dependent manner. (C) Model showing role of Ccr6-CCL20 in guiding innate-like lymphocyte to lymphatic sinus,
S1pr1-S1P in promoting trans-cellular migration into sinus, CD169 on macrophage (MØ) in mediating retention of CD169-ligandhi lymphocyte (green)
against lymph flow, and LFA1-ICAM1 in promoting adhesion and transmigration. Green arrows show cell migration and orange arrows show lymph
flow. LN, Lymph node; SCS, Subcapsular sinus.
DOI: 10.7554/eLife.18156.026
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(Arnon et al., 2011), internalization and desensitization of S1pr1, allowing the cells to respond to
cues (possibly including CCL20) that can promote their return to the parenchyma. This type of shut-
tling behavior has been described in the spleen for another population of innate-like lymphocytes,
the MZ B cells, with movement into the blood-rich MZ being S1pr1 dependent and return to the
parenchyma being CXCL13 dependent (Arnon et al., 2013). One function of MZ B cell shuttling is
to deliver immune complexes from blood to B cell follicles (Cinamon et al., 2008). It will be interest-
ing to see if cell shuttling in LNs contributes to cargo delivery from lymph to the LN parenchyma.
CD169 is abundantly expressed on the lymph-exposed heads of SCS macrophages as well as on
the tails that extend into the LN parenchyma (Phan et al., 2007). We show that CD169 supports
adhesion of innate-like lymphocytes in the sinus and helps restrain them against lymph flow. A num-
ber of in vitro studies have shown an ability of CD169 to support cell-cell adhesion (Crocker et al.,
1995; Crocker and Gordon, 1989; van den Berg et al., 2001). Recent work has also revealed that
CD169 on LN SCS macrophages can play a role in the capture of lymph-borne exosomes
(Saunderson et al., 2014) and retroviruses (Sewald et al., 2015). The present work builds upon
those observations to provide in vivo evidence that this Siglec family member can support shear
stress-resistant adhesion of cells. Although lymph flow rates in the mouse popliteal LN have not
been directly measured, a modeling study estimated wall shear stresses of several dyn/cm2 in the
SCS close to afferent lymphatic vessels (Jafarnejad et al., 2015). These shear stresses are similar to
those in blood vessels that support leukocyte adhesion (Finger et al., 1996). A recent genomics
study found that high endothelial venules in Peyer’s patches highly express St6gal1, an enzyme that
can generate ligands for CD22 (Siglec-2) (Lee et al., 2014). In transfer experiments, CD22-deficient
B cells showed reduced homing to Peyer’s patches (Lee et al., 2014). CD22 also contributes to B
cell homing to the bone marrow (Nitschke et al., 1999). These studies together with our work pro-
vide evidence that Siglecs are a second class of lectin, after the selectins, that functions in mediating
shear-resistant adhesion of cells. A key feature that facilitates selectin function is the high density of
glycosylated ligands on the target cell and the very rapid on- and off-rates of lectin-ligand interac-
tions (Rosen, 2004). We suggest that similar features contribute to the function of CD169 as a
shear-resistant adhesion receptor. The long ectodomain of CD169 (with 17 Ig-domains) also seems
likely to contribute to an ability to ‘capture’ cells that have become dislodged by lymph flow and to
allow their re-adhesion and subsequent transmigration. A similar activity may be involved in captur-
ing CD169-ligand high cells arriving in the SCS from the afferent lymphatic.
Our study provides evidence that LFA1 and ICAM1 are required for retaining IL7RahiCcr6+
innate-like lymphocytes in the SCS and supporting their return from the sinus to the parenchyma.
These findings are in accord with the well-established roles of LFA1 and ICAM1 in supporting adhe-
sion to and transmigration of lymphocytes across blood vessel endothelium into tissues (Rot and
von Andrian, 2004). However, they are in discord with a study showing that migration of BM-
derived DCs from the SCS into the LN parenchyma was integrin independent (La¨mmermann et al.,
2008). The basis for this discrepancy is not yet clear but might reflect general differences in the
properties of lymphocytes and BM-derived DCs. Moreover, integrins may contribute to DC traffick-
ing into LNs under conditions of inflammation (Teijeira et al., 2013). Our conclusion that LFA1 and
ICAM1 function during innate-like lymphocyte movement from the SCS into the LN parenchyma is
based on four sets of observations in mice treated with aL blocking antibody: (1) innate-like lympho-
cytes transiently accumulate in the SCS; (2) the accumulated cells exhibit an unusual elongated mor-
phology (suggesting a less adhesive state); (3) tracking analysis shows reduced numbers of cells
migrating from the SCS into the parenchyma; (4) the cells are more sensitive to dislodgement by
CD169 blocking antibody. We feel that the most parsimonious explanation for these data is that
LFA1 supports adhesive interactions between innate-like lymphocytes and ICAM1+ sinus-associated
cells (lymphatic endothelial cells, macrophages) that are needed for movement into the parenchyma.
However, given the heterogeneity of the innate-like lymphocyte population, we cannot exclude the
possibility that LFA1 blockade also decreases retention of some cells within the LN parenchyma,
thereby increasing their movement into the SCS. A study of naive lymphocyte egress from LNs
showed that LFA1 and ICAM1 can contribute to promoting retention of cells in the LN and this was
suggested to reflect a role for LFA1 in limiting the rate of cell movement across the endothelium
into the sinus lumen (Reichardt et al., 2013). More studies will be needed to fully address all the
functions of LFA1 and ICAM1 in innate-like lymphocyte migration dynamics.
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The migration of innate-like lymphocytes in close association with SCS macrophages seems likely
to ensure that factors made by the macrophages, such as IL1-family cytokines, can rapidly engage
the lymphocytes. It presumably also ensures that signaling in the reverse direction, from the innate-
like lymphocyte to the CD169+ cells, can take place efficiently. Such signaling may serve to augment
the antibacterial, antifungal or antiviral activities of the macrophages. The importance of cell move-
ment into the lumen of the SCS is not yet clear but might allow prompt surveillance of pathogens
and endogenous cells (e.g. cancer cells) arriving via the lymph, prior to their accessing the LN paren-
chyma. The greater CD169 coating of Vg4+gdT cells and their stronger dependence on CD169 for
retention in the SCS than the other innate-like lymphocytes suggests these cells interact more
strongly or in a more selective way with CD169+ macrophages. This likely reflects requirements for
recognizing and responding to unique ligands beyond IL1b and IL23.
Following Toxoplasma infection or after vaccinia virus injection, NK cell interaction with CD169+
macrophages is induced (Coombes et al., 2012; Garcia et al., 2012). These studies observed NK
cell movement on collagen fibers and of NK cells slowing or stopping in contact with CD169+ cells.
Whether collagen fibers guide the movement of IL7RahiCcr6+ cells needs further study, although in
contrast to NK cells, the IL7RahiCcr6+ cells had minimal expression of the collagen binding a2 integ-
rin (not shown and [Gray et al., 2012]). Another distinction between these cell types is that LN NK
cells lack Ccr6 (unpubl. obs). A previous study showed that NK1.1+ cells in the LN are concentrated
in medullary regions (Kastenmu¨ller et al., 2012), consistent with their homeostatic positioning being
controlled by cues other than CCL20. NK cell movement to the SCS might occur in response to
inflammation-induced chemoattractants such as CXCR3 ligands that can be upregulated in this
region and function in recruiting activated CD4 T cells and CD8 central memory cells (Garcia et al.,
2012; Groom et al., 2012; Sung et al., 2012). NKT cell interaction with SCS macrophages was
observed following immunization with a-galactosylceramide (Barral et al., 2010). Since 15–20% of
the IL7RahiCcr6+ innate-like lymphocytes are NKT cells (Gray et al., 2012), it is likely that these cells
are continually surveying the SCS macrophages in a manner similar to the bulk Cxcr6+ population
studied here. As well as macrophages, there are DCs in the SCS region (Gerner et al., 2015) and
the migration behavior we describe may help ensure efficient surveillance of SCS-associated DCs.
Following exposure to strong inflammatory signals, SCS macrophages move into the follicle
(Gaya et al., 2015). It will be interesting to examine how this reorganization modifies the innate-like
lymphocyte trafficking behavior.
Previous work has shown that the IL7RahiCcr6+gdT cells in peripheral LNs and related cells in the
dermis are precommitted to IL17 production, with stimulation by IL1b and IL23 being sufficient to
strongly promote IL17 production by these cells (Cai et al., 2011; Gray et al., 2011; Haas et al.,
2009; O’Brien and Born, 2015; Ramirez-Valle et al., 2015). Our studies here show that the
IL7RahiCcr6+abT cell population also readily produces IL17 upon IL1b and IL23 stimulation. These
cells are double negative for CD4 and CD8 (Gray et al., 2012). LN DN T cells highly express IL23R
and respond to this cytokine (Mizui et al., 2014; Riol-Blanco et al., 2010). Our findings in ASC-defi-
cient mice provide in vivo evidence that IL1-family cytokines are involved in activating the cells.
These observations are reminiscent of findings for innate-like CD8 T cells in LNs that rapidly make
IFNg upon cytokine (IL18 and IL12 or IL18 and IFNa) stimulation, and for various types of memory T
cells that make IFNg upon IL12 and IL18 exposure (Jameson et al., 2015; Kastenmu¨ller et al.,
2012). While our data suggest cytokines may be sufficient to activate the innate-like T cells under
some conditions, this does not exclude a role for TCR stimulation in promoting activation or aug-
menting responses under other conditions.
In summary, we demonstrate that IL17-committed innate-like lymphocytes survey the pathogen-
exposed surface of peripheral LNs and respond rapidly upon challenge with bacterial and fungal
pathogens. Ccr6-guided proximity to the SCS is important for these cytokine-driven responses.
S1pr1, CD169 and LFA1 function to promote migration between parenchyma and SCS in close asso-
ciation with CD169+ macrophages in a program that we suggest allows innate-like lymphocytes to
survey for a range of pathogen- and commensal-derived antigens and mount appropriately tailored
responses.
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Materials and methods
Mice
Wild-type C57BL/6NCr mice of 7–9 weeks of age were purchased from the National Cancer Institute
(Frederick, MD). Cxcr6GFP/+ (RRID:MGI:3616633), Ccr6GFP/+ (RRID:MGI:3852186), Ccr6+/– (RRID:
MGI:4359785), Pycard+/–, CAG-KiKGR+, S1pr1f/f, CreERt2+, Lyve1-Cre+Sphk1f/f Sphk2 –/–
mice (RRID:MGI:4421697), and Icam1+/– mice were previously described and were from JAX or from
an internal colony. CD169-DTR mice were provided by Masato Tanaka (Miyake et al., 2007). Litter-
mate mice were evenly distributed into control or treatment groups and mice of both groups were
co-caged whenever possible. All mice were adult and were studied between 7 and 20 weeks of age.
Animals were housed in a specific-pathogen-free environment in the Laboratory Animal Research
Center at the University of California, San Francisco, and all experiments conformed to ethical princi-
ples and guidelines approved by the Institutional Animal Care and Use Committee, protocol
approval number: AN107975-02.
FTY720 and AUY954 treatment
Mice were treated with FTY720 in saline at a dose of ~1 ug/g i.p. Mice were analyzed for Thy1-PE
labeling or CD169 bleb association at 6 hr or O/N post treatment. Control mice were treated with
saline i.p. AUY954 in saline was given i.p. in 300 ml at 300 mM. Mice were analyzed for CD169 bleb
association O/N post treatment. Control mice were treated with saline i.p.
aL and anti-CD169 blocking
100 mg aL blocking antibody (clone M17/4) or anti-CD169 blocking antibody (Ser4) or both antibod-
ies was injected i.v. Mice were analyzed 6 hr or 30 hr post treatment. For 3-day experiments, mice
were injected with 100 mg aL blocking antibody at day-3 and day-1, and experiments were done at
day 0.
Footpad bacterial challenge
Mice were challenged with 2  107 CFU of heat inactivated C. albicans, attenuated Yersinia pestis,
or 150 mg S. aureus bioparticle (Invitrogen, Cat S2859) through the footpad. Control mice were
treated with 25 ml saline. Draining popliteal LNs were dissected and analyzed 3 hr post challenge.
For IL17 staining, popliteal LN cells were incubated in Golgi plug for 2 hr at 37˚C, stained for surface
antigens, treated with BD Cytofix Buffer and Perm/Wash reagent (BD Biosciences), and stained with
anti-IL-17A.
In vivo Thy1-PE labeling
0.2 mg Thy1.2-PE antibody (30-H12) was injected through the footpad in 25 ml saline. Labeling was
done for 5 min. Draining popliteal LNs were harvested for flow cytometric or immunofluorescence
analysis.
Diphtheria toxin treatment
WT and CD169-DTR/+ were treated with 0.75 mg DT on Day-5 and Day-2. Experiments were per-
formed and the mice analyzed on Day 0.
Tamoxifen treatment
For full deletion, WT and S1pr1f/- ERcre+ mice were treated with tamoxifen at Day -5 to Day -1 and
analyzed on Day 0. For transient deletion, mice were treated with one dose on Day -2 and analyzed
on Day 0. Tamoxifen was dosed at 5 mg/mouse/day orally.
Flow cytometry
Cells were stained in ’FACS buffer’ (PBS with 0.1% sodium azide, 2% FBS and 1 mM EDTA) with anti-
bodies to TCRgd (GL3), TCRb (H57-597), IL17A (eBio17B7), Ccr6 (140706), IL7Ra (A7R34), CD3e
(clone 145-2C11), CD11b (clone Mac-1), Vg4 (clone UC3-10A6), CD90.2 (30-H12), S1pr1 (R&D,
MAB7089, clone 713412), anti-CD169 (clone MOMA-1 and clone Ser4); anti-scart2 antibody was
kindly provided by Dr. Klaus Karjalainen. Molecular Probes Monoclonal Antibody Labeling Kits
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(Invitrogen) were used to directly conjugate antibody to Alexafluor647 or Pacific Blue dyes. During
analysis, singlets were gated based on peak FSC-H/FSC-W and SSC-H/SSC-W. These gates encom-
passed more than 90% of total events and were set sufficiently wide to include singlet events of vari-
able size while avoiding the main doublet peak.
To detect IL-17A, cells were stimulated for 3 hr with 50 ng/ml phorbol 12-myristate 13-acetate
(PMA, Sigma) and 1 mg/ml Ionomycin (I, EMD Biosciences) or 3 hr with 10 ng/ml IL1b and 10 ng/ml
IL23 in Golgi plug (BD Biosciences) at 37˚C, stained for surface antigens, treated with BD Cytofix
Buffer and Perm/Wash reagent (BD Biosciences), and stained with anti-IL-17A.
CD169-Fc/R97A CD169-Fc FACS staining
1 mg/ml CD169-Fc or R97A CD169-Fc and 3 mg/ml anti-human IgG-PE antibody (Jackson Immunore-
search, Cat 109-116-098) was preincubated at 4˚C for 1 hr. After pre-binding, the mixture was added
to lymphocytes from LNs and staining was done for 1 hr on ice. Cells were then stained as normal
for FACS analysis.
In vivo Scart2 antibody labeling
5 mg Scart2 antibody in 100 ml volume of saline was injected s.c, draining inguinal lymph node was
analyzed by flow cytometry 1 hr post antibody injection.
Surgery and photoconversion
The mouse was anesthetized with ketamine, shaved and antiseptically prepared with 0.02% chlor-
hexidine gluconate. The mouse was then draped and a ~1.5 cm incision was made in the abdominal
skin to expose the left inguinal LN. A silver LED 415 (Prizmatix), set to maximum intensity, with a
high numerical aperture polymer optical fiber (core diameter, 1.5 mm) light guide and fiber col-
limater, was used as a 415 nm violet light source. During the 15 min exposure period, the tissue was
kept moist with saline. After photoconversion, the skin was closed with two autoclips (Thermo Fisher
Scientific). ~0.1 mg/kg buprenorphine in saline was given i.p immediately before and after surgery,
and every 4–12 hr as needed thereafter. The mice were closely monitored for signs of pain. Mice
were analyzed immediately before and after photoconversion, and 24 hr and 48 hr post photocon-
version. Flow cytometry was used to analyze left and right inguinal LN cells as previously described
(Gray et al., 2013). The staining was done with antibodies against Vg4, IL7Ra, Ccr6 and TCRb.
Parabiosis
Parabiosis surgery followed previously described procedures (Smith et al., 2015). Mirror-image inci-
sions at the left and right flanks were made through the skin and shorter incisions were made
through the abdominal wall. The peritoneal openings of the adjacent parabionts were sutured
together. Elbow and knee joints from each parabiont were sutured together and the skin of each
mouse was stapled (9 mm Autoclip, Clay Adams) to the skin of the adjacent parabiont. Each mouse
was injected subcutaneously with Baytril antibiotic and Buprenex as directed for pain and monitored
during recovery. For overall health and maintenance behavior, several recovery characteristics were
analyzed at various times after surgery, including paired weights and grooming behavior. Mice were
sacrificed for flow cytometric analysis two weeks post parabiotic surgery.
Intravital two-photon laser-scanning microscopy of popliteal LNs
Mice were anaesthetized by intraperitoneal injection of 10 ml/kg saline containing xylazine (1 mg/ml)
and ketamine (5 mg/ml). Maintenance doses of intramuscular injections of 4 ml/kg of xylazine (1 mg/
ml) and ketamine (5 mg/ml) were given approximately every 30 min. To image the popliteal LN, the
mouse’s hind leg was immobilized using thermal putty to a Biotherm stage warmer at 37˚C (Biogen-
ics) for the duration of the surgery and subsequent imaging. A small incision was made directly
behind the knee, and a ~0.5 cm square region of underlying tissue was exposed. The fat pad sur-
rounding the popliteal LN was carefully dissected away without damaging surrounding vasculature
and the afferent and efferent lymphatic vessels. After visualization of the popliteal LN, a 3D-printed
plastic tissue mount was attached to the surrounding tissue using Vetbond. The tissue mount was
immobilized with additional thermal putty, and the area above the LN was submerged in PBS for
imaging. Images were acquired with ZEN2009 (Carl Zeiss, Germany) using a 7 MP two-photon
Zhang et al. eLife 2016;5:e18156. DOI: 10.7554/eLife.18156 23 of 29
Research article Immunology
microscope (Carl Zeiss) equipped with a Chameleon laser (Coherent). For video acquisition, a series
of planes of 3 mm z-spacing spanning a depth of 90 mm were collected every 30 s. Excitation wave-
lengths were 905 nm. Emission filters were 500–550 nm for GFP, 570–640 nm for PE, and 450–490
for second harmonic signal. Videos were made and analysed with Imaris 7.4.2  64 (Bitplane). Two
hours prior to all imaging experiments, 2 mg CD11b-PE or 3 mg MOMA1-TxRed antibody was
injected through footpad. Cell tracking was performed using Imaris Bitplane software. Tracks gener-
ated using the software were manually confirmed and tracks that were a minimum of 5 min in dura-
tion were grouped according to whether they were exclusively in the parenchyma, exclusively in the
SCS or crossed between compartments. Each movie contained a total of between 100–300 tracks in
the region of interest. Approximately 15% of the Imaris generated tracks could not be confirmed as
representing the migration path of a single cell and these were excluded. To quantify the depth of
cells from the LN capsule in the imaging data, we used a computational procedure. First, a surface
object was created in Imaris over the LN capsule. The positions of both Cxcr6+ cells and CD11b+
subcapsular macrophages were determined using spots objects in Imaris. The minimum distance
between each spot and the capsule was determined using a custom MATLAB (MathWorks) script
and the ImarisXT interface. These data were exported into the R programming environment for anal-
ysis and plotting (ggplot2 package). The depth of the subcapsular sinus in individual LNs varied, and
for each experiment was computationally determined as the peak frequency on a plot of CD11b+
subcapsular macrophage’s depth below the LN capsule, minus 2 mm, which agreed across experi-
ments with visual estimates of the subcapsular sinus site. As the sinus size varied across experiments
from 15 to 40 mm, for the graphs of cell frequency against depth below the capsule the size of the
sinus was normalized across experiments to 20 mm. Only the region within the sinus was normalized.
Axis ratio was calculated as the ratio of ellipticity (prolate)/ellipticity (oblate). These dimensions were
obtained by first creating a surface object for each cell using Imaris Bitplane software. Final videos
were annotated and exported in Premiere (Adobe).
Transwell migration assay
Lymphocytes from LN were allowed to transmigrate for 4 hr across 5 mm transwell filters (Corning
Costar, Corning, NY) toward medium or SDF, CCL20, or S1P and enumerated by flow cytometry as
described (Ramirez-Valle et al., 2015).
Immunofluorescence microscopy
From paraformaldehyde-fixed tissue, 7 mm sections were prepared, as previously described
(Gray et al., 2012). In some cases, sections were fixed by acetone (Gray et al., 2012). Sections were
stained with the flowing antibodies: anti-Lyve1-A647, anti-CD3e-bio (clone 145-2C11), Goat anti-
CCL20 (AF760), Polyclonal Rabbit anti-GFP (Thermo Fisher Scientific), anti-B220-A647 (RA3-6B2),
anti-ICAM1-bio (3E2), anti-IL7Ra-A647 (A7R34), rat anti-scart2, Hamster anti-TCRgd (GL3), Donkey
anti-Goat-biotin Jackson immunoresearch), Goat anti-Armenian Hamster-bio (Jackson immunore-
search), Donkey anti-Rat-bio (Jackson immunoresearch), Anti-biotin-A488 (Jackson immunoresearch),
Anti-biotin-Cy3 (Jackson immunoresearch). Images were captured with a Zeiss AxioOberver Z1
inverted microscope.
Cxcr6-GFP cell enrichment
Isolated LN cells from 2–4 Cxcr6GFP/+ mice in complete RPMI media (with 2% FBS) were washed
twice and resuspended in 200~400 ml PBS (with 2% FBS). Cells were stained with anti CD62L-bio
(clone MEL-14), anti CD19-bio (clone MB19-1), anti CD11c-bio (clone N418), anti NK1.1-bio (clone
PK136) for 30 min on ice, washed twice, resuspended in 300 ml PBS (2% FBS) with 10~20 ml anti-Bio-
tin MACS beads (5 ml per mouse) and incubated on ice for 30 min. Cells were then washed with and
resuspended in 2 ml MACS buffer (PBS, 2% FBS, 2 mM EDTA, pH 7.2), filtered and loaded onto a
MACS column, following manufacturer instructions to negatively select Cxcr6GFP/+ cells. FACS was
used to check enrichment and yield.
In vitro adhesion assay
ICAM1 adhesion assay: 96-Well Costar Assay Plates (High binding polystyrene, Corning) were
coated with ICAM1 at 10 mg/ml concentration in 0.1 M Na2CO3/NaHCO3 pH 9.5 buffer at 4˚C O/N.
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Plates were then blocked with 1% BSA in RPMI for 30 min at room temperature. Plates were washed
twice with RPMI with 0.5% BSA. One million Lymphocytes were added and adhesion assays per-
formed at 37˚C for 30 min. A 200-ml pipette was used to wash cells (3x 12 o’clock, 3x 6 o’clock, 1x
12 o’clock, 3 o’clock, 6 o’clock and then 9 o’clock). After washing, cells were eluted with 5 mM
EDTA in RPMI with 0.5% BSA and incubation on ice for 15 min. Cells were stained and analyzed by
FACS. CD169-Fc/R97A CD169-Fc adhesion assay: Goat Anti-human IgG antibody (Jackson Immunor-
esearch) was coated on 96-Well Costar Assay Plate (High binding polystyrene, Corning) at 15 mg/ml
in 0.1 M Na2CO3/NaHCO3 pH9.5 buffer at 4 degree O/N. After coating, plates were washed twice
with PBS. After washing, 0.5 mg CD169-Fc or R97A CD169-Fc in 100 ml PBS was added. After 30 min
binding, plates were washed twice with PBS, and then blocked with RPMI with 1% BSA for 30 min at
room temp. After blocking, plates were washed twice with RPMI with 0.5% BSA. Enriched
Cxcr6GFP/+ cells or total LN cells (in RPMI with 0.5% BSA) were added to the plates. Adhesion assays
were performed at 37˚C for 30 min. After binding, cells were washed once (carefully using a 200 ml
pipette to remove the medium) with RPMI with 0.5% BSA solution and adherent cells were analyzed
by immunofluorescence microscopy or bright field microscopy for quantification.
Quantitative RT-PCR
Total RNA from sorted LECs or whole LN was isolated and reverse-transcribed, and quantitative
PCR was performed for IL1b, IL23a and CCL20 as described. Data were analyzed using the compara-
tive CT (2
 DDCt) method using Hprt as the reference.
Statistical analysis
Prism software (GraphPad) was used for all statistical analysis. Statistical comparisons were per-
formed using a two-tailed Student’s t-test. p values were considered significant when less than 0.05.
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